Dirks, Petra
Zingler, Vera
Leemhuis, Jost
Berthold, Heike
Hieke-Schulz, Stefanie
Wormser, David
Ziemssen, Tjalf
Funding for this research was provided by:
Roche Pharma AG
Article History
Received: 25 July 2019
Accepted: 28 February 2020
First Online: 14 March 2020
Ethics approval and consent to participate
: CONFIDENCE was evaluated by the Ethics Committee at the Technical University of Dresden, Germany (Ethikkommission an der Technischen Universität Dresden, Germany; 12 February 2018 and 10 April 2019; reference EK 62022018). All patients have to give signed informed consent to participate in the study.
: Not applicable.
: PD is an employee of Roche Pharma AG. VZ is an employee of F. Hoffmann-La Roche AG. JL and HB are employees of Roche Pharma AG and shareholders of F. Hoffmann-La Roche AG. SHS is employee of Roche Pharma AG. DW is an employee and shareholder of F. Hoffmann-La Roche AG. TZ has received grants and personal fees from Biogen, Novartis, Sanofi and Teva, and personal fees from Almirall, Bayer, F. Hoffmann-La Roche AG and Merck; he is a member of the editorial board (Associate Editor) of <i>BMC Neurology</i>. All authors received support for their contribution to this study as well as medical writing support for the development of this manuscript from Roche Pharma AG, Grenzach-Wyhlen, Germany.